Page 10 - Thyrocare Technologies News Today

Sensex makes a U-turn to end 244 pts lower as bulls stare at Covid 2.0 restrictions SECTIONS Sensex makes a U-turn to end 244 pts lower as bulls stare at Covid 2.0 restrictionsBy Share Synopsis Dalal Street failed to hold on to early gains due to weak global cues and the possibility of a stricter lockdown in Maharashtra, said an analyst. The S&P BSE Sensex index traded in a range of 1,040 points during the day. Related NEW DELHI: Domestic equity benchmarks continued to show volatile moves on T...

Dr A Velumani, managing director of Thyrocare Technologies talks of the hold up in testing and why the problem is universal. What is happening with the availability of testing kits? Reports suggest there is a huge shortage of RT-PCR kits, is that true? Is there enough capacity right now to fulfil the obligation of having 70% of all tests be RT-PCR in the state? There is no shortage of reagents, what is probably happening is that there is no more capacity. What that means is that laboratories ...

COVID-19 test labs across the country are at their limits, says Thyrocare Tech MD, Dr Velumani SECTIONS Last Updated: Apr 14, 2021, 12:56 PM IST Share Synopsis We came down to as little as 20% capacity in January, but, in these last eight weeks there has been 100% growth, every week. Amidst these rising loads, we cannot do more, without more people, says Dr Velumani. Agencies Dr A Velumani, managing director of Thyrocare Technologies talks of the hold up in testing and why the problem is univ...

Hopes of more vaccine approvals send Sensex rebounding after its worst day in 6 weeks SECTIONS Share Benchmark indices Sensex and Nifty partially recovered sharp losses in the previous session. The S&P BSE Sensex index surged 744.05 points or 1.55% to touch 48,627.43 at the strongest level of the day. Related NSE Explore Now NEW DELHI: As soon as stock market bulls got a whiff of likely more vaccine approvals in the coming days that would reduce the possibility of lockdowns, benchmark indices ...

Investors poorer by Rs 8.69 lakh crore as Covid 2.0 spooks D-Street bulls SECTIONS Share Synopsis Further imposition of lockdowns and all-time high Covid-19 cases have dragged the market to a monthly low. The S&P BSE Sensex index tumbled 1,897.88 points or 3.82% to hit 47,693.44 at the weakest level during the session. Related NSE Explore Now NEW DELHI: As India recorded its highest ever surge in new Covid-19 cases, investors dumped whatever they could get their hands on, pushing benchmark in...

Arindam Haldar, who joined Thyrocare Technologies as a chief executive officer (CEO) in September 2020, has expressed his intention of resigning from his current post for personal reasons. The nomination & remuneration committee, which discussed this matter at their meeting held on 5 April 2021, decided that Haldars resignation may be accepted and he may be relieved. On a consolidated basis, Thyrocares net profit surged 17.8% to Rs 32.39 crore on a 30.7% rise in net sales to Rs 138.27 crore in ...

At 7.40 am, SGX Nifty was ruling 15 points lower at 14,931. India in the last 24 hours reported the highest single-day spike of 1.31 lakh new Covid-19 cases. In the last four of the five days this week, India has reported cases of over 1 lakh. This comes at a time when several states are flagging vaccine shortages, risking the pace of Indias inoculation programme. Taking stock of the Covid situation, Prime Minister Narendra Modi on Thursday urged state governments to test more even if that m...

Here are the top stocks to track in todays session: Bharti Airtel: Department of Telecom (DoT) in an SC affidavit said it is planning to slap Videocon Telecommunications Ltds adjusted gross revenue (AGR) dues of Rs 1,376 crore on Bharti Airtel. However, Airtel has questioned the legal validity of the demand. Srei Infrastructure Finance: Its subsidiary Srei Equipment Finance said it had received an expression of interest for up to $250 million capital infusion in the company from international ...

Recent Covid-19 surge not as threatening as the first: Dr A Velumani, Thyrocare Technologies SECTIONS Last Updated: Apr 06, 2021, 02:02 PM IST Share Synopsis "In Mumbai, Maharashtra, the testing is high because the infections are high. Or infections are high because the testing is high. I think you need to ask analysts to find out what the data is saying." Agencies According to me, this wave will not be able to do the same amount of damage that the first wave did. I am very clear about it, said...

Synopsis "In Mumbai, Maharashtra, the testing is high because the infections are high. Or infections are high because the testing is high. I think you need to ask analysts to find out what the data is saying." Agencies According to me, this wave will not be able to do the same amount of damage that the first wave did. I am very clear about it, said Dr A Velumani, MD, Thyrocare Technologies. He added that tests have become affordable, and as a result more tests are conducted, more positive case...